‎ᅠᅠ‎A pharmaceutical company (hereafter, the company) developed Formula A, a prescription drug used to treat a common health condition. In the process of developing Formula A, the company also developed Formula B, a prescription drug derived from Formula A and used to treat the same condition. ᅠᅠFor each prescription drug, the company was granted a 6-year exclusivity period'. a period of six years during which a company holds exclusive rights to produce and sell a drug that it has developed. The 6-year exclusivity period for Formula A spanned Years 1-6, while the 6-year exclusivity period for Formula B spanned Years 5-10.ᅠᅠThe graph shows the company's annual revenue from sales of Formulas A and B for each of the Years 1-10. The company first earned revenue from sales of Formula B in Year 5. For each of the Years 9 and 10, the company's annual revenue from sales of Formula A was less than 10 million US dollars (US$). https://gmatclub.com/forum/download/file.php?mode=view&id=80579ᅠᅠFor each of the Years 1-10, the table shows the company's total revenue and total research and development (R&D) expenditures. https://gmatclub.com/forum/download/file.php?mode=view&id=80580 2024-08-23_19-06-01.png 2024-08-23_19-03-17.png

The 2,000 figure comes from the graph in tab 2, but that graph shows only revenue from sales of Formulas A and B, whereas the statement asks about the company’s total revenue , which is 2,500 in the table in tab 3. So 10% is 250, and 240 is not greater than 250. https://gmatclub.com/forum/download/file.php?id=88266 GMAT-Club-Forum-gj042498.png